Similarly, Matsumoto et al. (Matsumoto et al., 2016) found that increased CD4+ and CD8+ T cell infiltration is associated with better clinical outcomes in triple-negative breast cancer. The gene discussed is CD8A; the disease is triple-negative breast carcinoma.